Global Covid-19 Treatment Market Size, Status and Forecast 2020-2026

ID: 1207104 25 May 2020 Region : Global 129 Pages
Covid-19

COVID-19

Understand the influence of COVID-19 on the Covid-19 Treatment Market with our analysts monitoring the situation across the globe.

This report focuses on the global Covid-19 Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Covid-19 Treatment development in North America, Europe, China, Japan, South Korea, Middle East, Southeast Asia and Central & South America. The key players covered in this study Applied DNA Sciences, Inc Codagenix GeoVax Labs, Inc. Takis Biotech Evvivax Zydus Cadila MIGAL Galilee Research Institute Generex Biotechnology Corporation Moderna Therapeutics Novavax Bravovax Ascletis Pharma Janssen Pharmaceuticals Altimmune Greffex Inc. CanSino Biologics, Inc. ExpreS2ion Biotechnologies ApS Clover Biopharmaceuticals Vaxil Bio Ltd. iBio Pharma Inc Tonix Pharmaceuticals Curevac ImmunoPrecise Market segment by Type, the product can be split into by Treatment Type Respiratory Support Circulatory Support. Convalescent Plasma Therapy Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin) Antimicrobial Therapy Renal Failure and Renal Replacement Therapy Lung Replacement Therapy Immunotherapy Other therapeutic measures by Severity Degree Light Ordinary Heavy Critical Convalescence Respiratory support including oxygen therapy, high-flow nasal catheter oxygen therapy or non-invasive mechanical ventilation, invasive mechanical ventilation, extracorporeal membrane pneumonectomy (ECMO). Circulatory support refers to use vasoactive drug on the base of full fluid resuscitation and improved microcirculation. For else, antiviral medicine includs a-interferon, lopinavir/ritonavir, ribavirin, etc. Market segment by Application, split into Children Adult Special Groups Special groups refers to pregnants and others. Market segment by Regions/Countries, this report covers North America Europe China Japan South Korea Middle East Southeast Asia Central & South America The study objectives of this report are: To analyze global Covid-19 Treatment status, future forecast, growth opportunity, key market and key players. To present the Covid-19 Treatment development in North America, Europe, China, Japan, South Korea, Middle East, Southeast Asia and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of Covid-19 Treatment are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Covid-19 Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Covid-19 Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Respiratory Support 1.4.3 Circulatory Support. 1.4.4 Convalescent Plasma Therapy 1.4.5 Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin) 1.4.6 Antimicrobial Therapy 1.4.7 Renal Failure and Renal Replacement Therapy 1.4.8 Lung Replacement Therapy 1.4.9 Immunotherapy 1.4.10 Other therapeutic measures 1.5 Market by Application 1.5.1 Global Covid-19 Treatment Market Share by Application: 2020 VS 2026 1.5.2 Children 1.5.3 Adult 1.5.4 Special Groups 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Covid-19 Treatment Market Perspective (2015-2026) 2.2 Covid-19 Treatment Growth Trends by Regions 2.2.1 Covid-19 Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Covid-19 Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Covid-19 Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Covid-19 Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Covid-19 Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Covid-19 Treatment Players by Market Size 3.1.1 Global Top Covid-19 Treatment Players by Revenue (2015-2020) 3.1.2 Global Covid-19 Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Covid-19 Treatment Market Concentration Ratio 3.2.1 Global Covid-19 Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Covid-19 Treatment Revenue in 2019 3.3 Covid-19 Treatment Key Players Head office and Area Served 3.4 Key Players Covid-19 Treatment Product Solution and Service 3.5 Date of Enter into Covid-19 Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Covid-19 Treatment Historic Market Size by Type (2015-2020) 4.2 Global Covid-19 Treatment Forecasted Market Size by Type (2021-2026) 5 Covid-19 Treatment Breakdown Data by Application (2015-2026) 5.1 Global Covid-19 Treatment Market Size by Application (2015-2020) 5.2 Global Covid-19 Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Covid-19 Treatment Market Size (2015-2020) 6.2 Covid-19 Treatment Key Players in North America (2019-2020) 6.3 North America Covid-19 Treatment Market Size by Type (2015-2020) 6.4 North America Covid-19 Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Covid-19 Treatment Market Size (2015-2020) 7.2 Covid-19 Treatment Key Players in Europe (2019-2020) 7.3 Europe Covid-19 Treatment Market Size by Type (2015-2020) 7.4 Europe Covid-19 Treatment Market Size by Application (2015-2020) 8 China 8.1 China Covid-19 Treatment Market Size (2015-2020) 8.2 Covid-19 Treatment Key Players in China (2019-2020) 8.3 China Covid-19 Treatment Market Size by Type (2015-2020) 8.4 China Covid-19 Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Covid-19 Treatment Market Size (2015-2020) 9.2 Covid-19 Treatment Key Players in Japan (2019-2020) 9.3 Japan Covid-19 Treatment Market Size by Type (2015-2020) 9.4 Japan Covid-19 Treatment Market Size by Application (2015-2020) 10 South Korea 10.1 South Korea Covid-19 Treatment Market Size (2015-2020) 10.2 Covid-19 Treatment Key Players in South Korea (2019-2020) 10.3 South Korea Covid-19 Treatment Market Size by Type (2015-2020) 10.4 South Korea Covid-19 Treatment Market Size by Application (2015-2020) 11 Middle East 11.1 Middle East Covid-19 Treatment Market Size (2015-2020) 11.2 Covid-19 Treatment Key Players in Middle East (2019-2020) 11.3 Middle East Covid-19 Treatment Market Size by Type (2015-2020) 11.4 Middle East Covid-19 Treatment Market Size by Application (2015-2020) 12 Southeast Asia 12.1 Southeast Asia Covid-19 Treatment Market Size (2015-2020) 12.2 Covid-19 Treatment Key Players in Southeast Asia (2019-2020) 12.3 Southeast Asia Covid-19 Treatment Market Size by Type (2015-2020) 12.4 Southeast Asia Covid-19 Treatment Market Size by Application (2015-2020) 13 Central & South America 13.1 Central & South America Covid-19 Treatment Market Size (2015-2020) 13.2 Covid-19 Treatment Key Players in Central & South America (2019-2020) 13.3 Central & South America Covid-19 Treatment Market Size by Type (2015-2020) .4 Central & South America Covid-19 Treatment Market Size by Application (2015-2020) 14 Key Players Profiles 14.1 Applied DNA Sciences, Inc 14.1.1 Applied DNA Sciences, Inc Company Details 14.1.2 Applied DNA Sciences, Inc Business Overview and Its Total Revenue 14.1.3 Applied DNA Sciences, Inc Covid-19 Treatment Introduction 14.1.4 Applied DNA Sciences, Inc Revenue in Covid-19 Treatment Business (2015-2020)) 14.1.5 Applied DNA Sciences, Inc Recent Development 14.2 Codagenix 14.2.1 Codagenix Company Details 14.2.2 Codagenix Business Overview and Its Total Revenue 14.2.3 Codagenix Covid-19 Treatment Introduction 14.2.4 Codagenix Revenue in Covid-19 Treatment Business (2015-2020) 14.2.5 Codagenix Recent Development 14.3 GeoVax Labs, Inc. 14.3.1 GeoVax Labs, Inc. Company Details 14.3.2 GeoVax Labs, Inc. Business Overview and Its Total Revenue 14.3.3 GeoVax Labs, Inc. Covid-19 Treatment Introduction 14.3.4 GeoVax Labs, Inc. Revenue in Covid-19 Treatment Business (2015-2020) 14.3.5 GeoVax Labs, Inc. Recent Development 14.4 Takis Biotech 14.4.1 Takis Biotech Company Details 14.4.2 Takis Biotech Business Overview and Its Total Revenue 14.4.3 Takis Biotech Covid-19 Treatment Introduction 14.4.4 Takis Biotech Revenue in Covid-19 Treatment Business (2015-2020) 14.4.5 Takis Biotech Recent Development 14.5 Evvivax 14.5.1 Evvivax Company Details 14.5.2 Evvivax Business Overview and Its Total Revenue 14.5.3 Evvivax Covid-19 Treatment Introduction 14.5.4 Evvivax Revenue in Covid-19 Treatment Business (2015-2020) 14.5.5 Evvivax Recent Development 14.6 Zydus Cadila 14.6.1 Zydus Cadila Company Details 14.6.2 Zydus Cadila Business Overview and Its Total Revenue 14.6.3 Zydus Cadila Covid-19 Treatment Introduction 14.6.4 Zydus Cadila Revenue in Covid-19 Treatment Business (2015-2020) 14.6.5 Zydus Cadila Recent Development 14.7 MIGAL Galilee Research Institute 14.7.1 MIGAL Galilee Research Institute Company Details 14.7.2 MIGAL Galilee Research Institute Business Overview and Its Total Revenue 14.7.3 MIGAL Galilee Research Institute Covid-19 Treatment Introduction 14.7.4 MIGAL Galilee Research Institute Revenue in Covid-19 Treatment Business (2015-2020) 14.7.5 MIGAL Galilee Research Institute Recent Development 14.8 Generex Biotechnology Corporation 14.8.1 Generex Biotechnology Corporation Company Details 14.8.2 Generex Biotechnology Corporation Business Overview and Its Total Revenue 14.8.3 Generex Biotechnology Corporation Covid-19 Treatment Introduction 14.8.4 Generex Biotechnology Corporation Revenue in Covid-19 Treatment Business (2015-2020) 14.8.5 Generex Biotechnology Corporation Recent Development 14.9 Moderna Therapeutics 14.9.1 Moderna Therapeutics Company Details 14.9.2 Moderna Therapeutics Business Overview and Its Total Revenue 14.9.3 Moderna Therapeutics Covid-19 Treatment Introduction 14.9.4 Moderna Therapeutics Revenue in Covid-19 Treatment Business (2015-2020) 14.9.5 Moderna Therapeutics Recent Development 14.10 Novavax 14.10.1 Novavax Company Details 14.10.2 Novavax Business Overview and Its Total Revenue 14.10.3 Novavax Covid-19 Treatment Introduction 14.10.4 Novavax Revenue in Covid-19 Treatment Business (2015-2020) 14.10.5 Novavax Recent Development 14.11 Bravovax 10.11.1 Bravovax Company Details 10.11.2 Bravovax Business Overview and Its Total Revenue 10.11.3 Bravovax Covid-19 Treatment Introduction 10.11.4 Bravovax Revenue in Covid-19 Treatment Business (2015-2020) 10.11.5 Bravovax Recent Development 14.12 Ascletis Pharma 10.12.1 Ascletis Pharma Company Details 10.12.2 Ascletis Pharma Business Overview and Its Total Revenue 10.12.3 Ascletis Pharma Covid-19 Treatment Introduction 10.12.4 Ascletis Pharma Revenue in Covid-19 Treatment Business (2015-2020) 10.12.5 Ascletis Pharma Recent Development 14.13 Janssen Pharmaceuticals 10.13.1 Janssen Pharmaceuticals Company Details 10.13.2 Janssen Pharmaceuticals Business Overview and Its Total Revenue 10.13.3 Janssen Pharmaceuticals Covid-19 Treatment Introduction 10.13.4 Janssen Pharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020) 10.13.5 Janssen Pharmaceuticals Recent Development 14.14 Altimmune 10.14.1 Altimmune Company Details 10.14.2 Altimmune Business Overview and Its Total Revenue 10.14.3 Altimmune Covid-19 Treatment Introduction 10.14.4 Altimmune Revenue in Covid-19 Treatment Business (2015-2020) 10.14.5 Altimmune Recent Development 14.15 Greffex Inc. 10.15.1 Greffex Inc. Company Details 10.15.2 Greffex Inc. Business Overview and Its Total Revenue 10.15.3 Greffex Inc. Covid-19 Treatment Introduction 10.15.4 Greffex Inc. Revenue in Covid-19 Treatment Business (2015-2020) 10.15.5 Greffex Inc. Recent Development 14.16 CanSino Biologics, Inc. 10.16.1 CanSino Biologics, Inc. Company Details 10.16.2 CanSino Biologics, Inc. Business Overview and Its Total Revenue 10.16.3 CanSino Biologics, Inc. Covid-19 Treatment Introduction 10.16.4 CanSino Biologics, Inc. Revenue in Covid-19 Treatment Business (2015-2020) 10.16.5 CanSino Biologics, Inc. Recent Development 14.17 ExpreS2ion Biotechnologies ApS 10.17.1 ExpreS2ion Biotechnologies ApS Company Details 10.17.2 ExpreS2ion Biotechnologies ApS Business Overview and Its Total Revenue 10.17.3 ExpreS2ion Biotechnologies ApS Covid-19 Treatment Introduction 10.17.4 ExpreS2ion Biotechnologies ApS Revenue in Covid-19 Treatment Business (2015-2020) 10.17.5 ExpreS2ion Biotechnologies ApS Recent Development 14.18 Clover Biopharmaceuticals 10.18.1 Clover Biopharmaceuticals Company Details 10.18.2 Clover Biopharmaceuticals Business Overview and Its Total Revenue 10.18.3 Clover Biopharmaceuticals Covid-19 Treatment Introduction 10.18.4 Clover Biopharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020) 10.18.5 Clover Biopharmaceuticals Recent Development 14.19 Vaxil Bio Ltd. 10.19.1 Vaxil Bio Ltd. Company Details 10.19.2 Vaxil Bio Ltd. Business Overview and Its Total Revenue 10.19.3 Vaxil Bio Ltd. Covid-19 Treatment Introduction 10.19.4 Vaxil Bio Ltd. Revenue in Covid-19 Treatment Business (2015-2020) 10.19.5 Vaxil Bio Ltd. Recent Development 14.20 iBio Pharma Inc 10.20.1 iBio Pharma Inc Company Details 10.20.2 iBio Pharma Inc Business Overview and Its Total Revenue 10.20.3 iBio Pharma Inc Covid-19 Treatment Introduction 10.20.4 iBio Pharma Inc Revenue in Covid-19 Treatment Business (2015-2020) 10.20.5 iBio Pharma Inc Recent Development 14.21 Tonix Pharmaceuticals 10.21.1 Tonix Pharmaceuticals Company Details 10.21.2 Tonix Pharmaceuticals Business Overview and Its Total Revenue 10.21.3 Tonix Pharmaceuticals Covid-19 Treatment Introduction 10.21.4 Tonix Pharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020) 10.21.5 Tonix Pharmaceuticals Recent Development 14.22 Curevac 10.22.1 Curevac Company Details 10.22.2 Curevac Business Overview and Its Total Revenue 10.22.3 Curevac Covid-19 Treatment Introduction 10.22.4 Curevac Revenue in Covid-19 Treatment Business (2015-2020) 10.22.5 Curevac Recent Development 14.23 ImmunoPrecise 10.23.1 ImmunoPrecise Company Details 10.23.2 ImmunoPrecise Business Overview and Its Total Revenue 10.23.3 ImmunoPrecise Covid-19 Treatment Introduction 10.23.4 ImmunoPrecise Revenue in Covid-19 Treatment Business (2015-2020) 10.23.5 ImmunoPrecise Recent Development 15 Analyst's Viewpoints/Conclusions 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Disclaimer 16.3 Author Details

List of Tables Table 1. Covid-19 Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Covid-19 Treatment Revenue Table 3. Ranking of Global Top Covid-19 Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Covid-19 Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Respiratory Support Table 6. Key Players of Circulatory Support. Table 7. Key Players of Convalescent Plasma Therapy Table 8. Key Players of Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin) Table 9. Key Players of Antimicrobial Therapy Table 10. Key Players of Renal Failure and Renal Replacement Therapy Table 11. Key Players of Lung Replacement Therapy Table 12. Key Players of Immunotherapy Table 13. Key Players of Other therapeutic measures Table 14. Global Covid-19 Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 15. Global Covid-19 Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 16. Global Covid-19 Treatment Market Size by Regions (2015-2020) (US$ Million) Table 17. Global Covid-19 Treatment Market Share by Regions (2015-2020) Table 18. Global Covid-19 Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 19. Global Covid-19 Treatment Market Share by Regions (2021-2026) Table 20. Market Top Trends Table 21. Key Drivers: Impact Analysis Table 22. Key Challenges Table 23. Covid-19 Treatment Market Growth Strategy Table 24. Main Points Interviewed from Key Covid-19 Treatment Players Table 25. Global Covid-19 Treatment Revenue by Players (2015-2020) (Million US$) Table 26. Global Covid-19 Treatment Market Share by Players (2015-2020) Table 27. Global Top Covid-19 Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Treatment as of 2019) Table 28. Global Covid-19 Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 29. Key Players Headquarters and Area Served Table 30. Key Players Covid-19 Treatment Product Solution and Service Table 31. Date of Enter into Covid-19 Treatment Market Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Covid-19 Treatment Market Size by Type (2015-2020) (Million US$) Table 34. Global Covid-19 Treatment Market Size Share by Type (2015-2020) Table 35. Global Covid-19 Treatment Revenue Market Share by Type (2021-2026) Table 36. Global Covid-19 Treatment Market Size Share by Application (2015-2020) Table 37. Global Covid-19 Treatment Market Size by Application (2015-2020) (Million US$) Table 38. Global Covid-19 Treatment Market Size Share by Application (2021-2026) Table 39. North America Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$) Table 40. North America Key Players Covid-19 Treatment Market Share (2019-2020) Table 41. North America Covid-19 Treatment Market Size by Type (2015-2020) (Million US$) Table 42. North America Covid-19 Treatment Market Share by Type (2015-2020) Table 43. North America Covid-19 Treatment Market Size by Application (2015-2020) (Million US$) Table 44. North America Covid-19 Treatment Market Share by Application (2015-2020) Table 45. Europe Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$) Table 46. Europe Key Players Covid-19 Treatment Market Share (2019-2020) Table 47. Europe Covid-19 Treatment Market Size by Type (2015-2020) (Million US$) Table 48. Europe Covid-19 Treatment Market Share by Type (2015-2020) Table 49. Europe Covid-19 Treatment Market Size by Application (2015-2020) (Million US$) Table 50. Europe Covid-19 Treatment Market Share by Application (2015-2020) Table 51. China Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$) Table 52. China Key Players Covid-19 Treatment Market Share (2019-2020) Table 53. China Covid-19 Treatment Market Size by Type (2015-2020) (Million US$) Table 54. China Covid-19 Treatment Market Share by Type (2015-2020) Table 55. China Covid-19 Treatment Market Size by Application (2015-2020) (Million US$) Table 56. China Covid-19 Treatment Market Share by Application (2015-2020) Table 57. Japan Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$) Table 58. Japan Key Players Covid-19 Treatment Market Share (2019-2020) Table 59. Japan Covid-19 Treatment Market Size by Type (2015-2020) (Million US$) Table 60. Japan Covid-19 Treatment Market Share by Type (2015-2020) Table 61. Japan Covid-19 Treatment Market Size by Application (2015-2020) (Million US$) Table 62. Japan Covid-19 Treatment Market Share by Application (2015-2020) Table 63. South Korea Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$) Table 64. South Korea Key Players Covid-19 Treatment Market Share (2019-2020) Table 65. South Korea Covid-19 Treatment Market Size by Type (2015-2020) (Million US$) Table 66. South Korea Covid-19 Treatment Market Share by Type (2015-2020) Table 67. South Korea Covid-19 Treatment Market Size by Application (2015-2020) (Million US$) Table 68. South Korea Covid-19 Treatment Market Share by Application (2015-2020) Table 69. Middle East Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$) Table 70. Middle East Key Players Covid-19 Treatment Market Share (2019-2020) Table 71. Middle East Covid-19 Treatment Market Size by Type (2015-2020) (Million US$) Table 72. Middle East Covid-19 Treatment Market Share by Type (2015-2020) Table 73. Middle East Covid-19 Treatment Market Size by Application (2015-2020) (Million US$) Table 74. Middle East Covid-19 Treatment Market Share by Application (2015-2020) Table 75. Southeast Asia Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$) Table 76. Southeast Asia Key Players Covid-19 Treatment Market Share (2019-2020) Table 77. Southeast Asia Covid-19 Treatment Market Size by Type (2015-2020) (Million US$) Table 78. Southeast Asia Covid-19 Treatment Market Share by Type (2015-2020) Table 79. Southeast Asia Covid-19 Treatment Market Size by Application (2015-2020) (Million US$) Table 80. Southeast Asia Covid-19 Treatment Market Share by Application (2015-2020) Table 81. Central & South America Key Players Covid-19 Treatment Revenue (2019-2020) (Million US$) Table 82. Central & South America Key Players Covid-19 Treatment Market Share (2019-2020) Table 83. Central & South America Covid-19 Treatment Market Size by Type (2015-2020) (Million US$) Table 84. Central & South America Covid-19 Treatment Market Share by Type (2015-2020) Table 85. Central & South America Covid-19 Treatment Market Size by Application (2015-2020) (Million US$) Table 86. Central & South America Covid-19 Treatment Market Share by Application (2015-2020) Table 87. Applied DNA Sciences, Inc Company Details Table 88. Applied DNA Sciences, Inc Business Overview Table 89. Applied DNA Sciences, Inc Product Table 90. Applied DNA Sciences, Inc Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 91. Applied DNA Sciences, Inc Recent Development Table 92. Codagenix Company Details Table 93. Codagenix Business Overview Table 94. Codagenix Product Table 95. Codagenix Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 96. Codagenix Recent Development Table 97. GeoVax Labs, Inc. Company Details Table 98. GeoVax Labs, Inc. Business Overview Table 99. GeoVax Labs, Inc. Product Table 100. GeoVax Labs, Inc. Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 101. GeoVax Labs, Inc. Recent Development Table 102. Takis Biotech Company Details Table 103. Takis Biotech Business Overview Table 104. Takis Biotech Product Table 105. Takis Biotech Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 106. Takis Biotech Recent Development Table 107. Evvivax Company Details Table 108. Evvivax Business Overview Table 109. Evvivax Product Table 110. Evvivax Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 111. Evvivax Recent Development Table 112. Zydus Cadila Company Details Table 113. Zydus Cadila Business Overview Table 114. Zydus Cadila Product Table 115. Zydus Cadila Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 116. Zydus Cadila Recent Development Table 117. MIGAL Galilee Research Institute Company Details Table 118. MIGAL Galilee Research Institute Business Overview Table 119. MIGAL Galilee Research Institute Product Table 120. MIGAL Galilee Research Institute Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 121. MIGAL Galilee Research Institute Recent Development Table 122. Generex Biotechnology Corporation Business Overview Table 123. Generex Biotechnology Corporation Product Table 124. Generex Biotechnology Corporation Company Details Table 125. Generex Biotechnology Corporation Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 126. Generex Biotechnology Corporation Recent Development Table 127. Moderna Therapeutics Company Details Table 128. Moderna Therapeutics Business Overview Table 129. Moderna Therapeutics Product Table 130. Moderna Therapeutics Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 131. Moderna Therapeutics Recent Development Table 132. Novavax Company Details Table 133. Novavax Business Overview Table 134. Novavax Product Table 135. Novavax Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 136. Novavax Recent Development Table 137. Bravovax Company Details Table 138. Bravovax Business Overview Table 139. Bravovax Product Table 140. Bravovax Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 141. Bravovax Recent Development Table 142. Ascletis Pharma Company Details Table 143. Ascletis Pharma Business Overview Table 144. Ascletis Pharma Product Table 145. Ascletis Pharma Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 146. Ascletis Pharma Recent Development Table 147. Janssen Pharmaceuticals Company Details Table 148. Janssen Pharmaceuticals Business Overview Table 149. Janssen Pharmaceuticals Product Table 150. Janssen Pharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 151. Janssen Pharmaceuticals Recent Development Table 152. Altimmune Company Details Table 153. Altimmune Business Overview Table 154. Altimmune Product Table 155. Altimmune Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 156. Altimmune Recent Development Table 157. Greffex Inc. Company Details Table 158. Greffex Inc. Business Overview Table 159. Greffex Inc. Product Table 160. Greffex Inc. Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 161. Greffex Inc. Recent Development Table 162. CanSino Biologics, Inc. Company Details Table 163. CanSino Biologics, Inc. Business Overview Table 164. CanSino Biologics, Inc. Product Table 165. CanSino Biologics, Inc. Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 166. CanSino Biologics, Inc. Recent Development Table 167. ExpreS2ion Biotechnologies ApS Company Details Table 168. ExpreS2ion Biotechnologies ApS Business Overview Table 169. ExpreS2ion Biotechnologies ApS Product Table 170. ExpreS2ion Biotechnologies ApS Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 171. ExpreS2ion Biotechnologies ApS Recent Development Table 172. Clover Biopharmaceuticals Company Details Table 173. Clover Biopharmaceuticals Business Overview Table 174. Clover Biopharmaceuticals Product Table 175. Clover Biopharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 176. Clover Biopharmaceuticals Recent Development Table 177. Vaxil Bio Ltd. Company Details Table 178. Vaxil Bio Ltd. Business Overview Table 179. Vaxil Bio Ltd. Product Table 180. Vaxil Bio Ltd. Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 181. Vaxil Bio Ltd. Recent Development Table 182. iBio Pharma Inc Company Details Table 183. iBio Pharma Inc Business Overview Table 184. iBio Pharma Inc Product Table 185. iBio Pharma Inc Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 186. iBio Pharma Inc Recent Development Table 187. Tonix Pharmaceuticals Company Details Table 188. Tonix Pharmaceuticals Business Overview Table 189. Tonix Pharmaceuticals Product Table 190. Tonix Pharmaceuticals Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 191. Tonix Pharmaceuticals Recent Development Table 192. Curevac Company Details Table 193. Curevac Business Overview Table 194. Curevac Product Table 195. Curevac Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 196. Curevac Recent Development Table 197. ImmunoPrecise Company Details Table 198. ImmunoPrecise Business Overview Table 199. ImmunoPrecise Product Table 200. ImmunoPrecise Revenue in Covid-19 Treatment Business (2015-2020) (Million US$) Table 201. ImmunoPrecise Recent Development Table 202. Research Programs/Design for This Report Table 203. Key Data Information from Secondary Sources Table 204. Key Data Information from Primary Sources List of Figures Figure 1. Global Covid-19 Treatment Market Share by Type: 2020 VS 2026 Figure 2. Respiratory Support Features Figure 3. Circulatory Support. Features Figure 4. Convalescent Plasma Therapy Features Figure 5. Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin) Features Figure 6. Antimicrobial Therapy Features Figure 7. Renal Failure and Renal Replacement Therapy Features Figure 8. Lung Replacement Therapy Features Figure 9. Immunotherapy Features Figure 10. Other therapeutic measures Features Figure 11. Global Covid-19 Treatment Market Share by Application: 2020 VS 2026 Figure 12. Children Case Studies Figure 13. Adult Case Studies Figure 14. Special Groups Case Studies Figure 15. Covid-19 Treatment Report Years Considered Figure 16. Global Covid-19 Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 17. Global Covid-19 Treatment Market Share by Regions: 2020 VS 2026 Figure 18. Global Covid-19 Treatment Market Share by Regions (2021-2026) Figure 19. Porter's Five Forces Analysis Figure 20. Global Covid-19 Treatment Market Share by Players in 2019 Figure 21. Global Top Covid-19 Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Treatment as of 2019 Figure 22. The Top 10 and 5 Players Market Share by Covid-19 Treatment Revenue in 2019 Figure 23. North America Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Europe Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 25. China Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Japan Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 27. South Korea Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 28. Middle East Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 29. Southeast Asia Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 30. Central & South America Covid-19 Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 31. Applied DNA Sciences, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Applied DNA Sciences, Inc Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 33. Codagenix Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Codagenix Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 35. GeoVax Labs, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. GeoVax Labs, Inc. Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 37. Takis Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Takis Biotech Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 39. Evvivax Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Evvivax Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 41. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Zydus Cadila Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 43. MIGAL Galilee Research Institute Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. MIGAL Galilee Research Institute Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 45. Generex Biotechnology Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Generex Biotechnology Corporation Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 47. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Moderna Therapeutics Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 49. Novavax Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Novavax Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 51. Bravovax Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Bravovax Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 53. Ascletis Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Ascletis Pharma Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 55. Janssen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 56. Janssen Pharmaceuticals Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 57. Altimmune Total Revenue (US$ Million): 2019 Compared with 2018 Figure 58. Altimmune Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 59. Greffex Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 60. Greffex Inc. Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 61. CanSino Biologics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 62. CanSino Biologics, Inc. Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 63. ExpreS2ion Biotechnologies ApS Total Revenue (US$ Million): 2019 Compared with 2018 Figure 64. ExpreS2ion Biotechnologies ApS Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 65. Clover Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 66. Clover Biopharmaceuticals Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 67. Vaxil Bio Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 68. Vaxil Bio Ltd. Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 69. iBio Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 70. iBio Pharma Inc Revenue Growth Rate in Covid-19 Treatment Business (2015-2020) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
• Impact of COVID on supply/demand scenario, trade landscape & supply chain
• How market participants are preparing/strategizing to combat the impact
• How does the short-term & long-term scenario for Covid-19 Treatment Market looks like

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]